Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Journal of Virology|March 14, 2003
Human immunodeficiency virus type 1 (HIV-1) Vpr enhances expression from unintegrated HIV-1 DNABetty Poon, Irvin S Y ChenJournal of Virology|July 27, 2007
Vpr is required for efficient Nef expression from unintegrated human immunodeficiency virus type 1 DNABetty Poon, Michael A Chang, Irvin S Y ChenJournal of Virus Eradication|March 10, 2017
Highlights from the Third Biennial Strategies for an HIV Cure Meeting: 14-16 November 2016, Bethesda, MD, USADiane Lawrence, Lillian Kuo, Elizabeth Church, et al.Clinical and Vaccine Immunology : CVI|February 23, 2007
Use of a novel chimeric mouse model with a functionally active human immune system to study human immunodeficiency virus type 1 infectionDong Sung An, Betty Poon, Raphael Ho Tsong Fang, et al.Current HIV Research|October 28, 2005
Rapid size dependent deletion of foreign gene sequences inserted into attenuated HIV-1 upon infection in vivo: implications for vaccine developmentDavid G Brooks, Michael D Cohen, Beth D Jamieson, et al.Proceedings of the National Academy of Sciences of the United States of America|August 3, 2007
Stable reduction of CCR5 by RNAi through hematopoietic stem cell transplant in non-human primatesDong Sung An, Robert E Donahue, Masakazu Kamata, et al.American Journal of Infection Control|July 28, 2021
Vapourized hydrogen peroxide decontamination in a hospital setting inactivates SARS-CoV-2 and HCoV-229E without compromising filtration efficiency of unexpired N95 respiratorsNatasha Christie-Holmes, Rachel Tyli, Patrick Budylowski, et al.Cell & Bioscience|December 9, 2021
Intranasal HD-Ad vaccine protects the upper and lower respiratory tracts of hACE2 mice against SARS-CoV-2Huibi Cao, Juntao Mai, Zhichang Zhou, et al.Science Translational Medicine|May 24, 2023
A multi-specific, multi-affinity antibody platform neutralizes sarbecoviruses and confers protection against SARS-CoV-2 in vivoClare Burn Aschner, Krithika Muthuraman, Iga Kucharska, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 26, 2023
Identification of an Optimized Receptor-Binding Domain Subunit Vaccine against SARS-CoV-2Hong Yu, Liam J Worrall, Thorsten Berger, et al.Pageof 1